Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dynein axonemal heavy chain 11 is a large motor protein forming a critical component of the ciliary outer dynein arm, functioning as an ATPase that generates the force required for beating of motile cilia and flagella by moving toward the minus end of microtubules[1][5][6]. DNAH11 localizes to the *proximal region* of the respiratory cilia axoneme, and its activity is vital for proper ciliary bending and waveform generation. The protein is essential for embryonic left-right axis determination, effective mucociliary clearance in the respiratory tract, and normal sperm motility[2][4][6][7]. Mutations in the DNAH11 gene lead to *structure-function defects* in cilia, causing primary ciliary dyskinesia (often with normal ultrastructure but abnormal beating), situs inversus, infertility in males, and sometimes congenital heart defects; pathogenic variants can serve as diagnostic genetic markers but have not been targeted pharmacologically[3][4][6].
Not applicable. No known drugs directly target DNAH11; mechanisms described are for loss-of-function mutations causing impaired force generation in cilia[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dynein axonemal heavy chain 11 (DNAH11).